nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylcysteine—SLCO1B1—Mycophenolate mofetil—systemic scleroderma	0.164	0.404	CbGbCtD
Acetylcysteine—SLC22A6—Captopril—systemic scleroderma	0.134	0.33	CbGbCtD
Acetylcysteine—SLCO1B1—Methotrexate—systemic scleroderma	0.0657	0.162	CbGbCtD
Acetylcysteine—SLC7A11—forelimb zeugopod—systemic scleroderma	0.0478	0.321	CbGeAlD
Acetylcysteine—SLC22A6—Methotrexate—systemic scleroderma	0.0422	0.104	CbGbCtD
Acetylcysteine—ACY1—skin of body—systemic scleroderma	0.00841	0.0565	CbGeAlD
Acetylcysteine—ACY1—digestive system—systemic scleroderma	0.00673	0.0452	CbGeAlD
Acetylcysteine—CHUK—connective tissue—systemic scleroderma	0.00643	0.0432	CbGeAlD
Acetylcysteine—CHUK—skin of body—systemic scleroderma	0.0058	0.039	CbGeAlD
Acetylcysteine—ACY1—lung—systemic scleroderma	0.00562	0.0377	CbGeAlD
Acetylcysteine—SLC7A11—smooth muscle tissue—systemic scleroderma	0.00484	0.0325	CbGeAlD
Acetylcysteine—CHUK—digestive system—systemic scleroderma	0.00464	0.0312	CbGeAlD
Acetylcysteine—GRIN2D—tendon—systemic scleroderma	0.00453	0.0305	CbGeAlD
Acetylcysteine—IKBKB—connective tissue—systemic scleroderma	0.00437	0.0293	CbGeAlD
Acetylcysteine—IKBKB—smooth muscle tissue—systemic scleroderma	0.004	0.0268	CbGeAlD
Acetylcysteine—IKBKB—skin of body—systemic scleroderma	0.00395	0.0265	CbGeAlD
Acetylcysteine—GSS—smooth muscle tissue—systemic scleroderma	0.00392	0.0264	CbGeAlD
Acetylcysteine—CHUK—lung—systemic scleroderma	0.00388	0.026	CbGeAlD
Acetylcysteine—GSS—skin of body—systemic scleroderma	0.00387	0.026	CbGeAlD
Acetylcysteine—SLC7A11—digestive system—systemic scleroderma	0.00382	0.0257	CbGeAlD
Acetylcysteine—GRIN2A—tendon—systemic scleroderma	0.00337	0.0226	CbGeAlD
Acetylcysteine—SLC7A11—lung—systemic scleroderma	0.00319	0.0214	CbGeAlD
Acetylcysteine—IKBKB—digestive system—systemic scleroderma	0.00316	0.0212	CbGeAlD
Acetylcysteine—GSS—digestive system—systemic scleroderma	0.0031	0.0208	CbGeAlD
Acetylcysteine—IKBKB—tendon—systemic scleroderma	0.003	0.0202	CbGeAlD
Acetylcysteine—GSS—tendon—systemic scleroderma	0.00295	0.0198	CbGeAlD
Acetylcysteine—IKBKB—lung—systemic scleroderma	0.00264	0.0177	CbGeAlD
Acetylcysteine—GSS—lung—systemic scleroderma	0.00259	0.0174	CbGeAlD
Acetylcysteine—SLC7A11—Betamethasone—Mometasone—systemic scleroderma	0.00238	0.324	CbGdCrCtD
Acetylcysteine—SLC7A11—Dexamethasone—Mometasone—systemic scleroderma	0.00238	0.324	CbGdCrCtD
Acetylcysteine—SLCO1B1—digestive system—systemic scleroderma	0.00228	0.0153	CbGeAlD
Acetylcysteine—CHUK—TCR signaling in naïve CD8+ T cells—CSK—systemic scleroderma	0.00162	0.00971	CbGpPWpGaD
Acetylcysteine—CHUK—TNF receptor signaling pathway —TNFAIP3—systemic scleroderma	0.0016	0.00958	CbGpPWpGaD
Acetylcysteine—Stomatitis—Captopril—systemic scleroderma	0.00155	0.00571	CcSEcCtD
Acetylcysteine—CHUK—Hair Follicle Development: Induction (Part 1 of 3)—CTGF—systemic scleroderma	0.00153	0.00918	CbGpPWpGaD
Acetylcysteine—Mental disability—Mycophenolate mofetil—systemic scleroderma	0.00153	0.00564	CcSEcCtD
Acetylcysteine—CHUK—TCR signaling in naïve CD8+ T cells—CD247—systemic scleroderma	0.00153	0.00913	CbGpPWpGaD
Acetylcysteine—Anaphylactoid reaction—Lisinopril—systemic scleroderma	0.00151	0.00556	CcSEcCtD
Acetylcysteine—Ear pain—Mycophenolate mofetil—systemic scleroderma	0.0015	0.00553	CcSEcCtD
Acetylcysteine—CHUK—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—TNFAIP3—systemic scleroderma	0.0015	0.00896	CbGpPWpGaD
Acetylcysteine—Angioedema—Pentoxifylline—systemic scleroderma	0.0015	0.00552	CcSEcCtD
Acetylcysteine—CHUK—TCR signaling—CSK—systemic scleroderma	0.00149	0.00891	CbGpPWpGaD
Acetylcysteine—GRIN1—Spinal Cord Injury—SELP—systemic scleroderma	0.00149	0.0089	CbGpPWpGaD
Acetylcysteine—IKBKB—TCR signaling in naïve CD8+ T cells—CSK—systemic scleroderma	0.00147	0.00881	CbGpPWpGaD
Acetylcysteine—Asthma—Leflunomide—systemic scleroderma	0.00147	0.00541	CcSEcCtD
Acetylcysteine—Immune system disorder—Mometasone—systemic scleroderma	0.00147	0.00541	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Mometasone—systemic scleroderma	0.00146	0.00539	CcSEcCtD
Acetylcysteine—IKBKB—TNF receptor signaling pathway —TNFAIP3—systemic scleroderma	0.00145	0.00868	CbGpPWpGaD
Acetylcysteine—Nasopharyngitis—Mycophenolic acid—systemic scleroderma	0.00145	0.00534	CcSEcCtD
Acetylcysteine—CHUK—p75(NTR)-mediated signaling—RHOB—systemic scleroderma	0.00144	0.00864	CbGpPWpGaD
Acetylcysteine—Eye pain—Mycophenolate mofetil—systemic scleroderma	0.00142	0.00522	CcSEcCtD
Acetylcysteine—Pharyngitis—Captopril—systemic scleroderma	0.00142	0.00522	CcSEcCtD
Acetylcysteine—Face oedema—Lisinopril—systemic scleroderma	0.00141	0.0052	CcSEcCtD
Acetylcysteine—CHUK—TCR signaling—CD247—systemic scleroderma	0.0014	0.00838	CbGpPWpGaD
Acetylcysteine—Asthma—Mycophenolic acid—systemic scleroderma	0.0014	0.00516	CcSEcCtD
Acetylcysteine—IKBKB—Hair Follicle Development: Induction (Part 1 of 3)—CTGF—systemic scleroderma	0.00139	0.00832	CbGpPWpGaD
Acetylcysteine—GRIN1—Spinal Cord Injury—RHOB—systemic scleroderma	0.00139	0.00831	CbGpPWpGaD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—systemic scleroderma	0.00138	0.00511	CcSEcCtD
Acetylcysteine—IKBKB—TCR signaling in naïve CD8+ T cells—CD247—systemic scleroderma	0.00138	0.00828	CbGpPWpGaD
Acetylcysteine—CHUK—Osteopontin Signaling—MMP9—systemic scleroderma	0.00137	0.00819	CbGpPWpGaD
Acetylcysteine—CHUK—TCR signaling in naïve CD4+ T cells—CSK—systemic scleroderma	0.00136	0.00815	CbGpPWpGaD
Acetylcysteine—IKBKB—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—TNFAIP3—systemic scleroderma	0.00136	0.00812	CbGpPWpGaD
Acetylcysteine—IKBKB—TCR signaling—CSK—systemic scleroderma	0.00135	0.00808	CbGpPWpGaD
Acetylcysteine—CHUK—BCR signaling pathway—CSK—systemic scleroderma	0.00135	0.00805	CbGpPWpGaD
Acetylcysteine—Oedema—Pentoxifylline—systemic scleroderma	0.00134	0.00493	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Pentoxifylline—systemic scleroderma	0.00134	0.00493	CcSEcCtD
Acetylcysteine—Flushing—Captopril—systemic scleroderma	0.00132	0.00488	CcSEcCtD
Acetylcysteine—Shock—Pentoxifylline—systemic scleroderma	0.00132	0.00485	CcSEcCtD
Acetylcysteine—IKBKB—p75(NTR)-mediated signaling—RHOB—systemic scleroderma	0.00131	0.00783	CbGpPWpGaD
Acetylcysteine—Nasopharyngitis—Lisinopril—systemic scleroderma	0.00131	0.00481	CcSEcCtD
Acetylcysteine—Tachycardia—Pentoxifylline—systemic scleroderma	0.0013	0.00481	CcSEcCtD
Acetylcysteine—Skin disorder—Pentoxifylline—systemic scleroderma	0.0013	0.00479	CcSEcCtD
Acetylcysteine—SLC7A11—Betamethasone—Prednisone—systemic scleroderma	0.0013	0.176	CbGdCrCtD
Acetylcysteine—SLC7A11—Dexamethasone—Prednisone—systemic scleroderma	0.0013	0.176	CbGdCrCtD
Acetylcysteine—Hyperhidrosis—Pentoxifylline—systemic scleroderma	0.00129	0.00476	CcSEcCtD
Acetylcysteine—Angioedema—Mometasone—systemic scleroderma	0.00129	0.00476	CcSEcCtD
Acetylcysteine—CHUK—IL1-mediated signaling events—IL1A—systemic scleroderma	0.00129	0.00772	CbGpPWpGaD
Acetylcysteine—CHUK—TCR signaling in naïve CD4+ T cells—CD247—systemic scleroderma	0.00128	0.00766	CbGpPWpGaD
Acetylcysteine—Stomatitis—Leflunomide—systemic scleroderma	0.00128	0.0047	CcSEcCtD
Acetylcysteine—IKBKB—TCR signaling—CD247—systemic scleroderma	0.00127	0.0076	CbGpPWpGaD
Acetylcysteine—Asthma—Lisinopril—systemic scleroderma	0.00126	0.00465	CcSEcCtD
Acetylcysteine—Hypotension—Pentoxifylline—systemic scleroderma	0.00125	0.00461	CcSEcCtD
Acetylcysteine—IKBKB—Osteopontin Signaling—MMP9—systemic scleroderma	0.00124	0.00743	CbGpPWpGaD
Acetylcysteine—Bronchospasm—Lisinopril—systemic scleroderma	0.00124	0.00458	CcSEcCtD
Acetylcysteine—IKBKB—TCR signaling in naïve CD4+ T cells—CSK—systemic scleroderma	0.00124	0.00739	CbGpPWpGaD
Acetylcysteine—Face oedema—Mycophenolate mofetil—systemic scleroderma	0.00123	0.00455	CcSEcCtD
Acetylcysteine—Cough—Mometasone—systemic scleroderma	0.00123	0.00455	CcSEcCtD
Acetylcysteine—IKBKB—BCR signaling pathway—CSK—systemic scleroderma	0.00122	0.0073	CbGpPWpGaD
Acetylcysteine—Stomatitis—Mycophenolic acid—systemic scleroderma	0.00122	0.00449	CcSEcCtD
Acetylcysteine—Sweating—Mycophenolic acid—systemic scleroderma	0.0012	0.00441	CcSEcCtD
Acetylcysteine—Dyspnoea—Pentoxifylline—systemic scleroderma	0.00119	0.00439	CcSEcCtD
Acetylcysteine—Somnolence—Pentoxifylline—systemic scleroderma	0.00119	0.00438	CcSEcCtD
Acetylcysteine—Dyspepsia—Pentoxifylline—systemic scleroderma	0.00118	0.00434	CcSEcCtD
Acetylcysteine—IKBKB—IL1-mediated signaling events—IL1A—systemic scleroderma	0.00117	0.007	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream TCR signaling—HLA-DQB1—systemic scleroderma	0.00117	0.007	CbGpPWpGaD
Acetylcysteine—Pharyngitis—Leflunomide—systemic scleroderma	0.00117	0.0043	CcSEcCtD
Acetylcysteine—IKBKB—TCR signaling in naïve CD4+ T cells—CD247—systemic scleroderma	0.00116	0.00695	CbGpPWpGaD
Acetylcysteine—Anaphylactic shock—Mometasone—systemic scleroderma	0.00115	0.00425	CcSEcCtD
Acetylcysteine—Angioedema—Captopril—systemic scleroderma	0.00113	0.00418	CcSEcCtD
Acetylcysteine—CHUK—Interleukin-1 signaling—IL1A—systemic scleroderma	0.00113	0.00678	CbGpPWpGaD
Acetylcysteine—Immune system disorder—Azathioprine—systemic scleroderma	0.00112	0.00414	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Azathioprine—systemic scleroderma	0.00112	0.00414	CcSEcCtD
Acetylcysteine—Syncope—Captopril—systemic scleroderma	0.00111	0.0041	CcSEcCtD
Acetylcysteine—Pharyngitis—Mycophenolic acid—systemic scleroderma	0.00111	0.0041	CcSEcCtD
Acetylcysteine—Asthma—Mycophenolate mofetil—systemic scleroderma	0.00111	0.00408	CcSEcCtD
Acetylcysteine—CHUK—Apoptosis—IRF5—systemic scleroderma	0.00111	0.00661	CbGpPWpGaD
Acetylcysteine—Loss of consciousness—Captopril—systemic scleroderma	0.00109	0.00402	CcSEcCtD
Acetylcysteine—Cardiac disorder—Leflunomide—systemic scleroderma	0.00109	0.00402	CcSEcCtD
Acetylcysteine—Cough—Captopril—systemic scleroderma	0.00108	0.00399	CcSEcCtD
Acetylcysteine—Sweating—Lisinopril—systemic scleroderma	0.00108	0.00398	CcSEcCtD
Acetylcysteine—Urticaria—Pentoxifylline—systemic scleroderma	0.00106	0.00392	CcSEcCtD
Acetylcysteine—Immune system disorder—Leflunomide—systemic scleroderma	0.00106	0.00391	CcSEcCtD
Acetylcysteine—IKBKB—Downstream TCR signaling—HLA-DQB1—systemic scleroderma	0.00106	0.00635	CbGpPWpGaD
Acetylcysteine—Mediastinal disorder—Leflunomide—systemic scleroderma	0.00106	0.00391	CcSEcCtD
Acetylcysteine—Body temperature increased—Pentoxifylline—systemic scleroderma	0.00106	0.0039	CcSEcCtD
Acetylcysteine—Cardiac disorder—Mycophenolic acid—systemic scleroderma	0.00104	0.00384	CcSEcCtD
Acetylcysteine—CHUK—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—TNFAIP3—systemic scleroderma	0.00103	0.00615	CbGpPWpGaD
Acetylcysteine—Dyspnoea—Mometasone—systemic scleroderma	0.00103	0.00379	CcSEcCtD
Acetylcysteine—IKBKB—Interleukin-1 signaling—IL1A—systemic scleroderma	0.00103	0.00615	CbGpPWpGaD
Acetylcysteine—Angiopathy—Mycophenolic acid—systemic scleroderma	0.00102	0.00375	CcSEcCtD
Acetylcysteine—Dyspepsia—Mometasone—systemic scleroderma	0.00102	0.00374	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Captopril—systemic scleroderma	0.00101	0.00374	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Mycophenolic acid—systemic scleroderma	0.00101	0.00373	CcSEcCtD
Acetylcysteine—Pharyngitis—Lisinopril—systemic scleroderma	0.001	0.0037	CcSEcCtD
Acetylcysteine—IKBKB—Apoptosis—IRF5—systemic scleroderma	0.001	0.00599	CbGpPWpGaD
Acetylcysteine—CHUK—TCR Signaling Pathway—CD247—systemic scleroderma	0.000999	0.00598	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Breast Cancer Pathway—SMAD7—systemic scleroderma	0.000997	0.00597	CbGpPWpGaD
Acetylcysteine—Shock—Captopril—systemic scleroderma	0.000997	0.00367	CcSEcCtD
Acetylcysteine—CHUK—Structural Pathway of Interleukin 1 (IL-1)—IL1A—systemic scleroderma	0.000996	0.00596	CbGpPWpGaD
Acetylcysteine—SLC7A11—Cell surface interactions at the vascular wall—MMP1—systemic scleroderma	0.000995	0.00595	CbGpPWpGaD
Acetylcysteine—Tachycardia—Captopril—systemic scleroderma	0.000989	0.00365	CcSEcCtD
Acetylcysteine—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.000985	0.00363	CcSEcCtD
Acetylcysteine—CHUK—GAB1 signalosome—CSK—systemic scleroderma	0.000962	0.00575	CbGpPWpGaD
Acetylcysteine—Stomatitis—Mycophenolate mofetil—systemic scleroderma	0.000961	0.00354	CcSEcCtD
Acetylcysteine—Hypotension—Captopril—systemic scleroderma	0.000947	0.00349	CcSEcCtD
Acetylcysteine—CHUK—Toll-like Receptor Signaling Pathway—IRF5—systemic scleroderma	0.000946	0.00566	CbGpPWpGaD
Acetylcysteine—Pruritus—Pentoxifylline—systemic scleroderma	0.000946	0.00349	CcSEcCtD
Acetylcysteine—Sweating—Mycophenolate mofetil—systemic scleroderma	0.000945	0.00348	CcSEcCtD
Acetylcysteine—Flushing—Lisinopril—systemic scleroderma	0.000937	0.00346	CcSEcCtD
Acetylcysteine—Angioedema—Leflunomide—systemic scleroderma	0.000935	0.00345	CcSEcCtD
Acetylcysteine—IKBKB—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—TNFAIP3—systemic scleroderma	0.000933	0.00558	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—TOP1—systemic scleroderma	0.000927	0.00555	CbGpPWpGaD
Acetylcysteine—CHUK—TNF alpha Signaling Pathway—TNFAIP3—systemic scleroderma	0.00092	0.0055	CbGpPWpGaD
Acetylcysteine—Angiopathy—Lisinopril—systemic scleroderma	0.000916	0.00338	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic scleroderma	0.000916	0.00338	CcSEcCtD
Acetylcysteine—Body temperature increased—Mometasone—systemic scleroderma	0.000912	0.00336	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Lisinopril—systemic scleroderma	0.00091	0.00336	CcSEcCtD
Acetylcysteine—CHUK—Osteopontin-mediated events—MMP2—systemic scleroderma	0.000909	0.00544	CbGpPWpGaD
Acetylcysteine—IKBKB—TCR Signaling Pathway—CD247—systemic scleroderma	0.000906	0.00542	CbGpPWpGaD
Acetylcysteine—IKBKB—Structural Pathway of Interleukin 1 (IL-1)—IL1A—systemic scleroderma	0.000903	0.0054	CbGpPWpGaD
Acetylcysteine—Dyspnoea—Captopril—systemic scleroderma	0.000903	0.00333	CcSEcCtD
Acetylcysteine—Somnolence—Captopril—systemic scleroderma	0.000901	0.00332	CcSEcCtD
Acetylcysteine—GRIN1—SIDS Susceptibility Pathways—IL13—systemic scleroderma	0.000897	0.00536	CbGpPWpGaD
Acetylcysteine—Cough—Leflunomide—systemic scleroderma	0.000893	0.00329	CcSEcCtD
Acetylcysteine—Dyspepsia—Captopril—systemic scleroderma	0.000892	0.00329	CcSEcCtD
Acetylcysteine—Dizziness—Pentoxifylline—systemic scleroderma	0.000884	0.00326	CcSEcCtD
Acetylcysteine—Erythema—Lisinopril—systemic scleroderma	0.000879	0.00324	CcSEcCtD
Acetylcysteine—CHUK—IL-1 signaling pathway—IL1A—systemic scleroderma	0.000879	0.00526	CbGpPWpGaD
Acetylcysteine—Pharyngitis—Mycophenolate mofetil—systemic scleroderma	0.000878	0.00324	CcSEcCtD
Acetylcysteine—Syncope—Mycophenolic acid—systemic scleroderma	0.000875	0.00323	CcSEcCtD
Acetylcysteine—CHUK—TCR signaling—HLA-DQB1—systemic scleroderma	0.000874	0.00523	CbGpPWpGaD
Acetylcysteine—CHUK—B Cell Receptor Signaling Pathway—BLK—systemic scleroderma	0.000871	0.00521	CbGpPWpGaD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.000865	0.00319	CcSEcCtD
Acetylcysteine—Skin disorder—Azathioprine—systemic scleroderma	0.000859	0.00317	CcSEcCtD
Acetylcysteine—IKBKB—Toll-like Receptor Signaling Pathway—IRF5—systemic scleroderma	0.000858	0.00513	CbGpPWpGaD
Acetylcysteine—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.000858	0.00316	CcSEcCtD
Acetylcysteine—Cough—Mycophenolic acid—systemic scleroderma	0.000852	0.00314	CcSEcCtD
Acetylcysteine—Vomiting—Pentoxifylline—systemic scleroderma	0.00085	0.00313	CcSEcCtD
Acetylcysteine—Rash—Pentoxifylline—systemic scleroderma	0.000843	0.00311	CcSEcCtD
Acetylcysteine—Dermatitis—Pentoxifylline—systemic scleroderma	0.000842	0.0031	CcSEcCtD
Acetylcysteine—Face oedema—Prednisone—systemic scleroderma	0.000837	0.00309	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Leflunomide—systemic scleroderma	0.000835	0.00308	CcSEcCtD
Acetylcysteine—IKBKB—TNF alpha Signaling Pathway—TNFAIP3—systemic scleroderma	0.000834	0.00499	CbGpPWpGaD
Acetylcysteine—IKBKB—Apoptosis Modulation and Signaling—BLK—systemic scleroderma	0.000831	0.00497	CbGpPWpGaD
Acetylcysteine—Hypotension—Azathioprine—systemic scleroderma	0.000826	0.00305	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.000825	0.00304	CcSEcCtD
Acetylcysteine—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.000821	0.00303	CcSEcCtD
Acetylcysteine—Pruritus—Mometasone—systemic scleroderma	0.000816	0.00301	CcSEcCtD
Acetylcysteine—Tachycardia—Leflunomide—systemic scleroderma	0.000815	0.003	CcSEcCtD
Acetylcysteine—Skin disorder—Leflunomide—systemic scleroderma	0.000811	0.00299	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Leflunomide—systemic scleroderma	0.000807	0.00298	CcSEcCtD
Acetylcysteine—Angioedema—Lisinopril—systemic scleroderma	0.000803	0.00296	CcSEcCtD
Acetylcysteine—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.000803	0.00296	CcSEcCtD
Acetylcysteine—Body temperature increased—Captopril—systemic scleroderma	0.000801	0.00295	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000797	0.00294	CcSEcCtD
Acetylcysteine—IKBKB—IL-1 signaling pathway—IL1A—systemic scleroderma	0.000797	0.00477	CbGpPWpGaD
Acetylcysteine—Oedema—Mycophenolic acid—systemic scleroderma	0.000796	0.00294	CcSEcCtD
Acetylcysteine—Nausea—Pentoxifylline—systemic scleroderma	0.000794	0.00293	CcSEcCtD
Acetylcysteine—IKBKB—TCR signaling—HLA-DQB1—systemic scleroderma	0.000793	0.00474	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Receptor Signaling Pathway—BLK—systemic scleroderma	0.00079	0.00472	CbGpPWpGaD
Acetylcysteine—Syncope—Lisinopril—systemic scleroderma	0.000788	0.00291	CcSEcCtD
Acetylcysteine—Shock—Mycophenolic acid—systemic scleroderma	0.000784	0.00289	CcSEcCtD
Acetylcysteine—CHUK—Toll Like Receptor 4 (TLR4) Cascade—ITGAM—systemic scleroderma	0.000784	0.00469	CbGpPWpGaD
Acetylcysteine—Hypotension—Leflunomide—systemic scleroderma	0.00078	0.00288	CcSEcCtD
Acetylcysteine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000777	0.00287	CcSEcCtD
Acetylcysteine—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000774	0.00285	CcSEcCtD
Acetylcysteine—Loss of consciousness—Lisinopril—systemic scleroderma	0.000773	0.00285	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.00077	0.00284	CcSEcCtD
Acetylcysteine—Cough—Lisinopril—systemic scleroderma	0.000767	0.00283	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000763	0.00281	CcSEcCtD
Acetylcysteine—IKBKB—GMCSF-mediated signaling events—CCL2—systemic scleroderma	0.000752	0.0045	CbGpPWpGaD
Acetylcysteine—CHUK—TWEAK Signaling Pathway—CCL2—systemic scleroderma	0.00075	0.00448	CbGpPWpGaD
Acetylcysteine—Anaphylactoid reaction—Methotrexate—systemic scleroderma	0.000749	0.00276	CcSEcCtD
Acetylcysteine—Dyspnoea—Leflunomide—systemic scleroderma	0.000744	0.00274	CcSEcCtD
Acetylcysteine—Hypotension—Mycophenolic acid—systemic scleroderma	0.000744	0.00274	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000743	0.00274	CcSEcCtD
Acetylcysteine—CHUK—Regulation of toll-like receptor signaling pathway—IRF5—systemic scleroderma	0.000739	0.00442	CbGpPWpGaD
Acetylcysteine—Dyspepsia—Leflunomide—systemic scleroderma	0.000735	0.00271	CcSEcCtD
Acetylcysteine—Vomiting—Mometasone—systemic scleroderma	0.000733	0.0027	CcSEcCtD
Acetylcysteine—Rash—Mometasone—systemic scleroderma	0.000727	0.00268	CcSEcCtD
Acetylcysteine—Dermatitis—Mometasone—systemic scleroderma	0.000727	0.00268	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000721	0.00266	CcSEcCtD
Acetylcysteine—Oedema—Lisinopril—systemic scleroderma	0.000717	0.00265	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000717	0.00265	CcSEcCtD
Acetylcysteine—Pruritus—Captopril—systemic scleroderma	0.000717	0.00264	CcSEcCtD
Acetylcysteine—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—ITGAM—systemic scleroderma	0.000711	0.00425	CbGpPWpGaD
Acetylcysteine—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00071	0.00262	CcSEcCtD
Acetylcysteine—Somnolence—Mycophenolic acid—systemic scleroderma	0.000708	0.00261	CcSEcCtD
Acetylcysteine—GRIN2D—Alzheimers Disease—IL1B—systemic scleroderma	0.000708	0.00423	CbGpPWpGaD
Acetylcysteine—Shock—Lisinopril—systemic scleroderma	0.000706	0.0026	CcSEcCtD
Acetylcysteine—GRIN1—Spinal Cord Injury—IL1A—systemic scleroderma	0.000705	0.00422	CbGpPWpGaD
Acetylcysteine—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000704	0.00259	CcSEcCtD
Acetylcysteine—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000701	0.00259	CcSEcCtD
Acetylcysteine—Tachycardia—Lisinopril—systemic scleroderma	0.0007	0.00258	CcSEcCtD
Acetylcysteine—Body temperature increased—Azathioprine—systemic scleroderma	0.000699	0.00258	CcSEcCtD
Acetylcysteine—CHUK—Toll-Like Receptors Cascades—ITGAM—systemic scleroderma	0.000698	0.00417	CbGpPWpGaD
Acetylcysteine—Skin disorder—Lisinopril—systemic scleroderma	0.000697	0.00257	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000694	0.00256	CcSEcCtD
Acetylcysteine—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000691	0.00255	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000688	0.00254	CcSEcCtD
Acetylcysteine—Nausea—Mometasone—systemic scleroderma	0.000685	0.00253	CcSEcCtD
Acetylcysteine—CHUK—Osteopontin-mediated events—MMP9—systemic scleroderma	0.000683	0.00409	CbGpPWpGaD
Acetylcysteine—IKBKB—TWEAK Signaling Pathway—CCL2—systemic scleroderma	0.00068	0.00407	CbGpPWpGaD
Acetylcysteine—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000677	0.0025	CcSEcCtD
Acetylcysteine—SLC7A11—Hemostasis—SELP—systemic scleroderma	0.000674	0.00403	CbGpPWpGaD
Acetylcysteine—CHUK—IL1-mediated signaling events—IL1B—systemic scleroderma	0.000673	0.00403	CbGpPWpGaD
Acetylcysteine—Cough—Mycophenolate mofetil—systemic scleroderma	0.000672	0.00248	CcSEcCtD
Acetylcysteine—Hypotension—Lisinopril—systemic scleroderma	0.00067	0.00247	CcSEcCtD
Acetylcysteine—Dizziness—Captopril—systemic scleroderma	0.00067	0.00247	CcSEcCtD
Acetylcysteine—IKBKB—Regulation of toll-like receptor signaling pathway—IRF5—systemic scleroderma	0.00067	0.00401	CbGpPWpGaD
Acetylcysteine—Urticaria—Leflunomide—systemic scleroderma	0.000663	0.00245	CcSEcCtD
Acetylcysteine—CHUK—Regulation of toll-like receptor signaling pathway—TNFAIP3—systemic scleroderma	0.000661	0.00395	CbGpPWpGaD
Acetylcysteine—Body temperature increased—Leflunomide—systemic scleroderma	0.00066	0.00243	CcSEcCtD
Acetylcysteine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000651	0.0024	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000651	0.0024	CcSEcCtD
Acetylcysteine—Vomiting—Captopril—systemic scleroderma	0.000644	0.00237	CcSEcCtD
Acetylcysteine—Dyspnoea—Lisinopril—systemic scleroderma	0.00064	0.00236	CcSEcCtD
Acetylcysteine—Rash—Captopril—systemic scleroderma	0.000639	0.00236	CcSEcCtD
Acetylcysteine—Dermatitis—Captopril—systemic scleroderma	0.000638	0.00235	CcSEcCtD
Acetylcysteine—Somnolence—Lisinopril—systemic scleroderma	0.000638	0.00235	CcSEcCtD
Acetylcysteine—IKBKB—Toll-Like Receptors Cascades—ITGAM—systemic scleroderma	0.000633	0.00379	CbGpPWpGaD
Acetylcysteine—Dyspepsia—Lisinopril—systemic scleroderma	0.000631	0.00233	CcSEcCtD
Acetylcysteine—CHUK—MicroRNAs in cardiomyocyte hypertrophy—EDN1—systemic scleroderma	0.00063	0.00377	CbGpPWpGaD
Acetylcysteine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00063	0.00232	CcSEcCtD
Acetylcysteine—SLC7A11—Hemostasis—RHOB—systemic scleroderma	0.000629	0.00376	CbGpPWpGaD
Acetylcysteine—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000629	0.00232	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000629	0.00232	CcSEcCtD
Acetylcysteine—Asthma—Methotrexate—systemic scleroderma	0.000626	0.00231	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000619	0.00228	CcSEcCtD
Acetylcysteine—GRIN1—Axon guidance—RHOB—systemic scleroderma	0.000619	0.0037	CbGpPWpGaD
Acetylcysteine—Shock—Mycophenolate mofetil—systemic scleroderma	0.000618	0.00228	CcSEcCtD
Acetylcysteine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000615	0.00227	CcSEcCtD
Acetylcysteine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000613	0.00226	CcSEcCtD
Acetylcysteine—CHUK—Signaling by EGFR—CSK—systemic scleroderma	0.000613	0.00367	CbGpPWpGaD
Acetylcysteine—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000611	0.00225	CcSEcCtD
Acetylcysteine—IKBKB—IL1-mediated signaling events—IL1B—systemic scleroderma	0.00061	0.00365	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR in Cancer—CSK—systemic scleroderma	0.000608	0.00364	CbGpPWpGaD
Acetylcysteine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000608	0.00224	CcSEcCtD
Acetylcysteine—CHUK—IL-1 signaling pathway—CCL2—systemic scleroderma	0.000604	0.00361	CbGpPWpGaD
Acetylcysteine—GRIN2B—Axon guidance—RHOB—systemic scleroderma	0.000604	0.00361	CbGpPWpGaD
Acetylcysteine—Nausea—Captopril—systemic scleroderma	0.000602	0.00222	CcSEcCtD
Acetylcysteine—IKBKB—Regulation of toll-like receptor signaling pathway—TNFAIP3—systemic scleroderma	0.000599	0.00359	CbGpPWpGaD
Acetylcysteine—CHUK—TCR Signaling Pathway—IL1A—systemic scleroderma	0.000592	0.00354	CbGpPWpGaD
Acetylcysteine—CHUK—Interleukin-1 signaling—IL1B—systemic scleroderma	0.000591	0.00354	CbGpPWpGaD
Acetylcysteine—Pruritus—Leflunomide—systemic scleroderma	0.000591	0.00218	CcSEcCtD
Acetylcysteine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000587	0.00217	CcSEcCtD
Acetylcysteine—Dizziness—Azathioprine—systemic scleroderma	0.000585	0.00216	CcSEcCtD
Acetylcysteine—GRIN2A—Alzheimers Disease—IL1B—systemic scleroderma	0.000581	0.00348	CbGpPWpGaD
Acetylcysteine—CHUK—NOD pathway—IL1B—systemic scleroderma	0.00058	0.00347	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—CSK—systemic scleroderma	0.000573	0.00343	CbGpPWpGaD
Acetylcysteine—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—EDN1—systemic scleroderma	0.000571	0.00342	CbGpPWpGaD
Acetylcysteine—Urticaria—Lisinopril—systemic scleroderma	0.00057	0.0021	CcSEcCtD
Acetylcysteine—Body temperature increased—Lisinopril—systemic scleroderma	0.000567	0.00209	CcSEcCtD
Acetylcysteine—GRIN1—SIDS Susceptibility Pathways—IL1A—systemic scleroderma	0.000564	0.00337	CbGpPWpGaD
Acetylcysteine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000563	0.00208	CcSEcCtD
Acetylcysteine—Vomiting—Azathioprine—systemic scleroderma	0.000562	0.00207	CcSEcCtD
Acetylcysteine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00056	0.00207	CcSEcCtD
Acetylcysteine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000559	0.00206	CcSEcCtD
Acetylcysteine—Drowsiness—Methotrexate—systemic scleroderma	0.000558	0.00206	CcSEcCtD
Acetylcysteine—Rash—Azathioprine—systemic scleroderma	0.000557	0.00206	CcSEcCtD
Acetylcysteine—Dermatitis—Azathioprine—systemic scleroderma	0.000557	0.00205	CcSEcCtD
Acetylcysteine—Flushing—Prednisone—systemic scleroderma	0.000557	0.00205	CcSEcCtD
Acetylcysteine—GRIN1—EPH-Ephrin signaling—MMP2—systemic scleroderma	0.000553	0.00331	CbGpPWpGaD
Acetylcysteine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000553	0.00204	CcSEcCtD
Acetylcysteine—Dizziness—Leflunomide—systemic scleroderma	0.000552	0.00204	CcSEcCtD
Acetylcysteine—IKBKB—IL-1 signaling pathway—CCL2—systemic scleroderma	0.000548	0.00328	CbGpPWpGaD
Acetylcysteine—Stomatitis—Methotrexate—systemic scleroderma	0.000544	0.00201	CcSEcCtD
Acetylcysteine—Angiopathy—Prednisone—systemic scleroderma	0.000544	0.00201	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000543	0.002	CcSEcCtD
Acetylcysteine—Immune system disorder—Prednisone—systemic scleroderma	0.000542	0.002	CcSEcCtD
Acetylcysteine—GRIN2B—EPH-Ephrin signaling—MMP2—systemic scleroderma	0.00054	0.00323	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—ITGAM—systemic scleroderma	0.000538	0.00322	CbGpPWpGaD
Acetylcysteine—ACY1—Metabolism—HSPG2—systemic scleroderma	0.000538	0.00322	CbGpPWpGaD
Acetylcysteine—IKBKB—TCR Signaling Pathway—IL1A—systemic scleroderma	0.000537	0.00321	CbGpPWpGaD
Acetylcysteine—CHUK—TWEAK Signaling Pathway—MMP9—systemic scleroderma	0.000536	0.00321	CbGpPWpGaD
Acetylcysteine—IKBKB—Interleukin-1 signaling—IL1B—systemic scleroderma	0.000536	0.00321	CbGpPWpGaD
Acetylcysteine—Sweating—Methotrexate—systemic scleroderma	0.000535	0.00197	CcSEcCtD
Acetylcysteine—Vomiting—Leflunomide—systemic scleroderma	0.000531	0.00196	CcSEcCtD
Acetylcysteine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000529	0.00195	CcSEcCtD
Acetylcysteine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000527	0.00194	CcSEcCtD
Acetylcysteine—Rash—Leflunomide—systemic scleroderma	0.000526	0.00194	CcSEcCtD
Acetylcysteine—Dermatitis—Leflunomide—systemic scleroderma	0.000526	0.00194	CcSEcCtD
Acetylcysteine—IKBKB—NOD pathway—IL1B—systemic scleroderma	0.000526	0.00314	CbGpPWpGaD
Acetylcysteine—Nausea—Azathioprine—systemic scleroderma	0.000525	0.00194	CcSEcCtD
Acetylcysteine—Erythema—Prednisone—systemic scleroderma	0.000522	0.00192	CcSEcCtD
Acetylcysteine—CHUK—Signaling by Interleukins—IL1A—systemic scleroderma	0.000512	0.00306	CbGpPWpGaD
Acetylcysteine—Pruritus—Lisinopril—systemic scleroderma	0.000508	0.00187	CcSEcCtD
Acetylcysteine—GRIN1—Alzheimers Disease—IL1B—systemic scleroderma	0.000507	0.00303	CbGpPWpGaD
Acetylcysteine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000506	0.00187	CcSEcCtD
Acetylcysteine—Rash—Mycophenolic acid—systemic scleroderma	0.000502	0.00185	CcSEcCtD
Acetylcysteine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000502	0.00185	CcSEcCtD
Acetylcysteine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000499	0.00184	CcSEcCtD
Acetylcysteine—CHUK—B Cell Activation—BLK—systemic scleroderma	0.000498	0.00298	CbGpPWpGaD
Acetylcysteine—Pharyngitis—Methotrexate—systemic scleroderma	0.000497	0.00183	CcSEcCtD
Acetylcysteine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000497	0.00183	CcSEcCtD
Acetylcysteine—CHUK—AGE/RAGE pathway—MMP2—systemic scleroderma	0.000497	0.00297	CbGpPWpGaD
Acetylcysteine—Nausea—Leflunomide—systemic scleroderma	0.000496	0.00183	CcSEcCtD
Acetylcysteine—GRIN2B—Alzheimers Disease—IL1B—systemic scleroderma	0.000494	0.00296	CbGpPWpGaD
Acetylcysteine—IKBKB—TWEAK Signaling Pathway—MMP9—systemic scleroderma	0.000486	0.00291	CbGpPWpGaD
Acetylcysteine—GRIN1—Spinal Cord Injury—CCL2—systemic scleroderma	0.000485	0.0029	CbGpPWpGaD
Acetylcysteine—Angioedema—Prednisone—systemic scleroderma	0.000477	0.00176	CcSEcCtD
Acetylcysteine—Dizziness—Lisinopril—systemic scleroderma	0.000474	0.00175	CcSEcCtD
Acetylcysteine—Nausea—Mycophenolic acid—systemic scleroderma	0.000473	0.00174	CcSEcCtD
Acetylcysteine—Syncope—Prednisone—systemic scleroderma	0.000468	0.00173	CcSEcCtD
Acetylcysteine—CHUK—AGE/RAGE pathway—NOS3—systemic scleroderma	0.000465	0.00278	CbGpPWpGaD
Acetylcysteine—Cardiac disorder—Methotrexate—systemic scleroderma	0.000465	0.00172	CcSEcCtD
Acetylcysteine—IKBKB—Signaling by Interleukins—IL1A—systemic scleroderma	0.000464	0.00278	CbGpPWpGaD
Acetylcysteine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000463	0.00171	CcSEcCtD
Acetylcysteine—Loss of consciousness—Prednisone—systemic scleroderma	0.000459	0.00169	CcSEcCtD
Acetylcysteine—CHUK—IL-1 signaling pathway—IL1B—systemic scleroderma	0.000458	0.00274	CbGpPWpGaD
Acetylcysteine—Vomiting—Lisinopril—systemic scleroderma	0.000456	0.00168	CcSEcCtD
Acetylcysteine—Angiopathy—Methotrexate—systemic scleroderma	0.000455	0.00168	CcSEcCtD
Acetylcysteine—Immune system disorder—Methotrexate—systemic scleroderma	0.000453	0.00167	CcSEcCtD
Acetylcysteine—Rash—Lisinopril—systemic scleroderma	0.000452	0.00167	CcSEcCtD
Acetylcysteine—Dermatitis—Lisinopril—systemic scleroderma	0.000452	0.00167	CcSEcCtD
Acetylcysteine—IKBKB—B Cell Activation—BLK—systemic scleroderma	0.000452	0.0027	CbGpPWpGaD
Acetylcysteine—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000452	0.00167	CcSEcCtD
Acetylcysteine—IKBKB—AGE/RAGE pathway—MMP2—systemic scleroderma	0.00045	0.00269	CbGpPWpGaD
Acetylcysteine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000445	0.00164	CcSEcCtD
Acetylcysteine—GRIN1—Developmental Biology—RHOB—systemic scleroderma	0.000442	0.00264	CbGpPWpGaD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000441	0.00163	CcSEcCtD
Acetylcysteine—Erythema—Methotrexate—systemic scleroderma	0.000436	0.00161	CcSEcCtD
Acetylcysteine—GRIN2B—Developmental Biology—RHOB—systemic scleroderma	0.000431	0.00258	CbGpPWpGaD
Acetylcysteine—Nausea—Lisinopril—systemic scleroderma	0.000426	0.00157	CcSEcCtD
Acetylcysteine—Oedema—Prednisone—systemic scleroderma	0.000426	0.00157	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Prednisone—systemic scleroderma	0.000426	0.00157	CcSEcCtD
Acetylcysteine—CHUK—Interleukin-11 Signaling Pathway—TGFB1—systemic scleroderma	0.000426	0.00255	CbGpPWpGaD
Acetylcysteine—IKBKB—AGE/RAGE pathway—NOS3—systemic scleroderma	0.000422	0.00252	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—IRF5—systemic scleroderma	0.000422	0.00252	CbGpPWpGaD
Acetylcysteine—CHUK—Leptin signaling pathway—NOS3—systemic scleroderma	0.00042	0.00251	CbGpPWpGaD
Acetylcysteine—Shock—Prednisone—systemic scleroderma	0.000419	0.00155	CcSEcCtD
Acetylcysteine—GRIN1—EPH-Ephrin signaling—MMP9—systemic scleroderma	0.000416	0.00249	CbGpPWpGaD
Acetylcysteine—Tachycardia—Prednisone—systemic scleroderma	0.000416	0.00153	CcSEcCtD
Acetylcysteine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000416	0.00153	CcSEcCtD
Acetylcysteine—IKBKB—IL-1 signaling pathway—IL1B—systemic scleroderma	0.000415	0.00249	CbGpPWpGaD
Acetylcysteine—Skin disorder—Prednisone—systemic scleroderma	0.000414	0.00153	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Prednisone—systemic scleroderma	0.000412	0.00152	CcSEcCtD
Acetylcysteine—ACY1—Metabolism—CTGF—systemic scleroderma	0.000408	0.00244	CbGpPWpGaD
Acetylcysteine—GRIN2B—EPH-Ephrin signaling—MMP9—systemic scleroderma	0.000406	0.00243	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—IRF8—systemic scleroderma	0.000403	0.00241	CbGpPWpGaD
Acetylcysteine—CHUK—TNF alpha Signaling Pathway—CCL2—systemic scleroderma	0.0004	0.00239	CbGpPWpGaD
Acetylcysteine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.0004	0.00147	CcSEcCtD
Acetylcysteine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000396	0.00146	CcSEcCtD
Acetylcysteine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000396	0.00146	CcSEcCtD
Acetylcysteine—IKBKB—Interleukin-11 Signaling Pathway—TGFB1—systemic scleroderma	0.000386	0.00231	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—IRF5—systemic scleroderma	0.000382	0.00229	CbGpPWpGaD
Acetylcysteine—IKBKB—Leptin signaling pathway—NOS3—systemic scleroderma	0.000381	0.00228	CbGpPWpGaD
Acetylcysteine—Cough—Methotrexate—systemic scleroderma	0.000381	0.0014	CcSEcCtD
Acetylcysteine—Dyspepsia—Prednisone—systemic scleroderma	0.000375	0.00138	CcSEcCtD
Acetylcysteine—CHUK—AGE/RAGE pathway—MMP9—systemic scleroderma	0.000373	0.00223	CbGpPWpGaD
Acetylcysteine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000373	0.00138	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000369	0.00136	CcSEcCtD
Acetylcysteine—GRIN1—Spinal Cord Injury—IL1B—systemic scleroderma	0.000368	0.0022	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—IRF8—systemic scleroderma	0.000366	0.00219	CbGpPWpGaD
Acetylcysteine—IKBKB—TNF alpha Signaling Pathway—CCL2—systemic scleroderma	0.000363	0.00217	CbGpPWpGaD
Acetylcysteine—CHUK—Leptin signaling pathway—IL1B—systemic scleroderma	0.000357	0.00214	CbGpPWpGaD
Acetylcysteine—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000356	0.00131	CcSEcCtD
Acetylcysteine—CHUK—Cardiac Hypertrophic Response—TGFB1—systemic scleroderma	0.000356	0.00213	CbGpPWpGaD
Acetylcysteine—SLC7A11—NRF2 pathway—TGFB1—systemic scleroderma	0.00035	0.00209	CbGpPWpGaD
Acetylcysteine—GRIN1—Spinal Cord Injury—MMP9—systemic scleroderma	0.000347	0.00207	CbGpPWpGaD
Acetylcysteine—Skin disorder—Methotrexate—systemic scleroderma	0.000346	0.00128	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000344	0.00127	CcSEcCtD
Acetylcysteine—IKBKB—AGE/RAGE pathway—MMP9—systemic scleroderma	0.000339	0.00203	CbGpPWpGaD
Acetylcysteine—Urticaria—Prednisone—systemic scleroderma	0.000338	0.00125	CcSEcCtD
Acetylcysteine—Body temperature increased—Prednisone—systemic scleroderma	0.000337	0.00124	CcSEcCtD
Acetylcysteine—Hypotension—Methotrexate—systemic scleroderma	0.000333	0.00123	CcSEcCtD
Acetylcysteine—CHUK—Integrated Breast Cancer Pathway—MMP1—systemic scleroderma	0.000331	0.00198	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—IL1A—systemic scleroderma	0.000326	0.00195	CbGpPWpGaD
Acetylcysteine—IKBKB—Leptin signaling pathway—IL1B—systemic scleroderma	0.000324	0.00194	CbGpPWpGaD
Acetylcysteine—IKBKB—Cardiac Hypertrophic Response—TGFB1—systemic scleroderma	0.000323	0.00193	CbGpPWpGaD
Acetylcysteine—Dyspnoea—Methotrexate—systemic scleroderma	0.000317	0.00117	CcSEcCtD
Acetylcysteine—Somnolence—Methotrexate—systemic scleroderma	0.000317	0.00117	CcSEcCtD
Acetylcysteine—Hypersensitivity—Prednisone—systemic scleroderma	0.000314	0.00116	CcSEcCtD
Acetylcysteine—Dyspepsia—Methotrexate—systemic scleroderma	0.000313	0.00116	CcSEcCtD
Acetylcysteine—GSS—Metabolism—HSPG2—systemic scleroderma	0.000309	0.00185	CbGpPWpGaD
Acetylcysteine—CHUK—TCR Signaling Pathway—IL1B—systemic scleroderma	0.000309	0.00185	CbGpPWpGaD
Acetylcysteine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000307	0.00113	CcSEcCtD
Acetylcysteine—Pruritus—Prednisone—systemic scleroderma	0.000301	0.00111	CcSEcCtD
Acetylcysteine—GRIN1—SIDS Susceptibility Pathways—IL1B—systemic scleroderma	0.000294	0.00176	CbGpPWpGaD
Acetylcysteine—GRIN1—Spinal Cord Injury—TGFB1—systemic scleroderma	0.000286	0.00171	CbGpPWpGaD
Acetylcysteine—Urticaria—Methotrexate—systemic scleroderma	0.000283	0.00104	CcSEcCtD
Acetylcysteine—Dizziness—Prednisone—systemic scleroderma	0.000282	0.00104	CcSEcCtD
Acetylcysteine—Body temperature increased—Methotrexate—systemic scleroderma	0.000281	0.00104	CcSEcCtD
Acetylcysteine—IKBKB—TCR Signaling Pathway—IL1B—systemic scleroderma	0.00028	0.00168	CbGpPWpGaD
Acetylcysteine—CHUK—Toll-like Receptor Signaling Pathway—IL1B—systemic scleroderma	0.00028	0.00167	CbGpPWpGaD
Acetylcysteine—Vomiting—Prednisone—systemic scleroderma	0.000271	0.000999	CcSEcCtD
Acetylcysteine—SLC7A11—Hemostasis—MMP1—systemic scleroderma	0.00027	0.00161	CbGpPWpGaD
Acetylcysteine—Rash—Prednisone—systemic scleroderma	0.000269	0.000991	CcSEcCtD
Acetylcysteine—Dermatitis—Prednisone—systemic scleroderma	0.000268	0.00099	CcSEcCtD
Acetylcysteine—CHUK—Signaling by Interleukins—IL1B—systemic scleroderma	0.000267	0.0016	CbGpPWpGaD
Acetylcysteine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000262	0.000967	CcSEcCtD
Acetylcysteine—CHUK—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—systemic scleroderma	0.000254	0.00152	CbGpPWpGaD
Acetylcysteine—IKBKB—Toll-like Receptor Signaling Pathway—IL1B—systemic scleroderma	0.000253	0.00152	CbGpPWpGaD
Acetylcysteine—Nausea—Prednisone—systemic scleroderma	0.000253	0.000933	CcSEcCtD
Acetylcysteine—Pruritus—Methotrexate—systemic scleroderma	0.000252	0.000929	CcSEcCtD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—HLA-DQB1—systemic scleroderma	0.000252	0.0015	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by Interleukins—IL1B—systemic scleroderma	0.000242	0.00145	CbGpPWpGaD
Acetylcysteine—CHUK—TCR Signaling Pathway—TGFB1—systemic scleroderma	0.00024	0.00144	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—IL1A—systemic scleroderma	0.000239	0.00143	CbGpPWpGaD
Acetylcysteine—Dizziness—Methotrexate—systemic scleroderma	0.000235	0.000868	CcSEcCtD
Acetylcysteine—GSS—Metabolism—CTGF—systemic scleroderma	0.000234	0.0014	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—CSK—systemic scleroderma	0.000231	0.00138	CbGpPWpGaD
Acetylcysteine—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—systemic scleroderma	0.00023	0.00138	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—HLA-DQB1—systemic scleroderma	0.000228	0.00136	CbGpPWpGaD
Acetylcysteine—Vomiting—Methotrexate—systemic scleroderma	0.000226	0.000835	CcSEcCtD
Acetylcysteine—CHUK—Innate Immune System—ITGAM—systemic scleroderma	0.000226	0.00135	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—CD247—systemic scleroderma	0.000226	0.00135	CbGpPWpGaD
Acetylcysteine—Rash—Methotrexate—systemic scleroderma	0.000225	0.000828	CcSEcCtD
Acetylcysteine—Dermatitis—Methotrexate—systemic scleroderma	0.000224	0.000827	CcSEcCtD
Acetylcysteine—CHUK—Regulation of toll-like receptor signaling pathway—IL1B—systemic scleroderma	0.000218	0.00131	CbGpPWpGaD
Acetylcysteine—IKBKB—TCR Signaling Pathway—TGFB1—systemic scleroderma	0.000218	0.0013	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—CD247—systemic scleroderma	0.000217	0.0013	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—IL1A—systemic scleroderma	0.000217	0.0013	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—TNFAIP3—systemic scleroderma	0.000212	0.00127	CbGpPWpGaD
Acetylcysteine—Nausea—Methotrexate—systemic scleroderma	0.000212	0.00078	CcSEcCtD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	0.000211	0.00126	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—CSK—systemic scleroderma	0.000209	0.00125	CbGpPWpGaD
Acetylcysteine—GRIN1—Axon guidance—MMP2—systemic scleroderma	0.000206	0.00123	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—ITGAM—systemic scleroderma	0.000205	0.00123	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—CD247—systemic scleroderma	0.000205	0.00123	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by SCF-KIT—MMP9—systemic scleroderma	0.000203	0.00122	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—BLK—systemic scleroderma	0.000201	0.0012	CbGpPWpGaD
Acetylcysteine—GRIN2B—Axon guidance—MMP2—systemic scleroderma	0.0002	0.0012	CbGpPWpGaD
Acetylcysteine—IKBKB—Regulation of toll-like receptor signaling pathway—IL1B—systemic scleroderma	0.000198	0.00118	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—CD247—systemic scleroderma	0.000197	0.00118	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—NOS3—systemic scleroderma	0.000196	0.00117	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—TNFAIP3—systemic scleroderma	0.000192	0.00115	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—SMAD7—systemic scleroderma	0.000184	0.0011	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—BLK—systemic scleroderma	0.000182	0.00109	CbGpPWpGaD
Acetylcysteine—ACY1—Metabolism—NOS3—systemic scleroderma	0.000178	0.00106	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—IL1B—systemic scleroderma	0.00017	0.00102	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—TGFBI—systemic scleroderma	0.000168	0.001	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—CTLA4—systemic scleroderma	0.000165	0.000984	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	0.00016	0.000957	CbGpPWpGaD
Acetylcysteine—GRIN1—Axon guidance—MMP9—systemic scleroderma	0.000155	0.000925	CbGpPWpGaD
Acetylcysteine—GRIN2B—Axon guidance—MMP9—systemic scleroderma	0.000151	0.000901	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—CTLA4—systemic scleroderma	0.000149	0.000892	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—MMP2—systemic scleroderma	0.000147	0.000878	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—MMP2—systemic scleroderma	0.000143	0.000856	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CSK—systemic scleroderma	0.00014	0.000838	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IRF5—systemic scleroderma	0.000138	0.000824	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—HLA-DQB1—systemic scleroderma	0.000135	0.00081	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—HSPG2—systemic scleroderma	0.000134	0.000801	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—TGFB1—systemic scleroderma	0.000132	0.00079	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—ITGAM—systemic scleroderma	0.000132	0.000788	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IRF8—systemic scleroderma	0.000132	0.000788	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CD247—systemic scleroderma	0.000132	0.000788	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	0.000132	0.000787	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—TGFB1—systemic scleroderma	0.000129	0.000774	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CSK—systemic scleroderma	0.000129	0.000773	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—SMAD7—systemic scleroderma	0.000129	0.000769	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—CD40LG—systemic scleroderma	0.000128	0.000765	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CSK—systemic scleroderma	0.000127	0.00076	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IRF5—systemic scleroderma	0.000125	0.000747	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—IL1B—systemic scleroderma	0.000125	0.000745	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—TNFAIP3—systemic scleroderma	0.000123	0.000738	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—HLA-DQB1—systemic scleroderma	0.000123	0.000735	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—BLK—systemic scleroderma	0.000122	0.000729	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CD247—systemic scleroderma	0.000122	0.000727	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IRF8—systemic scleroderma	0.000119	0.000714	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—ITGAM—systemic scleroderma	0.000119	0.000714	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CD247—systemic scleroderma	0.000119	0.000714	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—SMAD7—systemic scleroderma	0.000117	0.000697	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—CD40LG—systemic scleroderma	0.000116	0.000694	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—IL1B—systemic scleroderma	0.000113	0.000676	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—TNFAIP3—systemic scleroderma	0.000112	0.000669	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—BLK—systemic scleroderma	0.00011	0.000661	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—MMP9—systemic scleroderma	0.00011	0.00066	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—MMP9—systemic scleroderma	0.000108	0.000643	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—NOS3—systemic scleroderma	0.000102	0.00061	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CTLA4—systemic scleroderma	9.98e-05	0.000597	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—RHOB—systemic scleroderma	9.94e-05	0.000595	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—HSPG2—systemic scleroderma	9.4e-05	0.000563	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—HSPG2—systemic scleroderma	9.38e-05	0.000561	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—TGFB1—systemic scleroderma	9.09e-05	0.000544	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CSK—systemic scleroderma	9.05e-05	0.000542	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CTLA4—systemic scleroderma	9.05e-05	0.000541	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—RHOB—systemic scleroderma	9.01e-05	0.000539	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—TGFB1—systemic scleroderma	8.86e-05	0.00053	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—HSPG2—systemic scleroderma	8.5e-05	0.000509	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—HLA-DQB1—systemic scleroderma	8.22e-05	0.000492	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CSK—systemic scleroderma	8.21e-05	0.000491	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IL1A—systemic scleroderma	7.8e-05	0.000467	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CD40LG—systemic scleroderma	7.76e-05	0.000464	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—HLA-DQB1—systemic scleroderma	7.45e-05	0.000446	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—CTGF—systemic scleroderma	7.13e-05	0.000426	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IL1A—systemic scleroderma	7.08e-05	0.000423	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CD40LG—systemic scleroderma	7.04e-05	0.000421	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—EDN1—systemic scleroderma	5.08e-05	0.000304	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—EDN1—systemic scleroderma	4.6e-05	0.000275	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—NOS3—systemic scleroderma	4.42e-05	0.000264	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IL1B—systemic scleroderma	4.07e-05	0.000243	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IL1B—systemic scleroderma	3.69e-05	0.000221	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CCL2—systemic scleroderma	3.47e-05	0.000208	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CCL2—systemic scleroderma	3.15e-05	0.000188	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—NOS3—systemic scleroderma	3.1e-05	0.000186	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—NOS3—systemic scleroderma	3.09e-05	0.000185	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—TGFB1—systemic scleroderma	2.92e-05	0.000175	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—NOS3—systemic scleroderma	2.8e-05	0.000168	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MMP9—systemic scleroderma	2.48e-05	0.000148	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MMP9—systemic scleroderma	2.25e-05	0.000135	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TGFB1—systemic scleroderma	2.04e-05	0.000122	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TGFB1—systemic scleroderma	1.85e-05	0.000111	CbGpPWpGaD
